This episode explores Canada’s evolving approach to CBD regulation, focusing on proposed changes that would allow low-dose cannabidiol products to be sold as Natural Health Products without a prescription. It covers the gaps in the current framework under the Cannabis Act, the results of public consultations, and Health Canada’s ongoing efforts to balance safety, access, and industry growth. The discussion also touches on implications for pharmacies, veterinary products, product labeling, and the broader impact on public health and the legal cannabis market.

 Tune in now to stay ahead of the regulatory curve and understand what’s coming next for CBD in Canada.